AJCC yc Stage Classification: When and How to Use
This presentation will explore the criteria and timing for the yc stage classification. It will demonstrate when it is used and how to properly assign it. Neoadjuvant therapy guidelines and grade post-therapy clinical will also be discussed.
This webinar is for:
- Certified Tumor Registrars
- Cancer Program Administrators
- Other allied health professionals
- Demonstrate use of AJCC yc stage classification.
- Utilize neoadjuvant therapy guidelines for AJCC staging.
- Apply grade post therapy clinical to appropriate cases.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest (see below for definitions).
The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Donna Gress, RHIT, CTR - Nothing to disclose
Ms. Gress is the Cancer Staging and Registry Operations Manager for the American Joint Committee on Cancer (AJCC) and Cancer Programs; Technical Editor of the AJCC Cancer Staging Manual 8th Edition, lead author of the manual’s Chapter 1 Principles of Cancer Staging and Version 9 Cervix Uteri. She is an active member of health information management and cancer registry professions and a past president of the National Cancer Registrars Association (NCRA), who received the NCRA Distinguished Member Award and twice received the NCRA Educational Achievement Award. Her work experience includes that of an RHIT and more than 40 years in the cancer registry field, with 27 years of experience in hospital cancer registries.
A Certificate of Completion will be awarded for this course.
1 continuing education credit for #2020-148 will be provided from National Cancer Registrars Association (NCRA), of which 1 hours meet the Category A requirement.
ACS Cancer Programs is an approved provider by the California Board of Registered Nursing, provider #CEP17437, for 1 contact hour.
- 0.00 AMA PRA Category 1 Credit™
- 1.00 CE Contact hours
- 1.00 Certificate of Completion